While acute respiratory infections are known to increase thrombosis risk [1], the incidence of
venous thromboembolic events (VTE) in patients with coronavirus disease 2019 (COVID-19) …

Background Venous thromboembolism (VTE) is a potentially fatal complication of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and thromboprophylaxis …

Background Coagulopathy is a common abnormality in patients with COVID‐19. However,
the exact incidence of venous thromboembolic event is unknown in anticoagulated, severe …

Background Cardiovascular complications, including myocardial infarction, ischemic stroke,
and pulmonary embolism, represent an important source of adverse outcomes in …

Objective The coronavirus disease of 2019 (COVID-19) due to SARS-CoV-2 infection has
been found to cause an increased risk of venous thrombo-embolism (VTE). The aims of the …

Background Evidence supports an excess of deaths during the COVID-19 pandemic. We
report the incidence and mortality of thrombo-embolic events (TE) during the COVID-19 …

Background Venous thromboembolism (VTE) is a frequent complication in critically ill
patients with coronavirus disease 2019 (COVID-19) and is associated with mortality. Early …

COVID-19 is associated with a variety of clinical complications including coagulopathy,
which frequently results in venous thromboembolism (VTE). Retrospective analyses …

This study aims to review the available literature pertinent to vascular complications in
COVID-19. A systematic search was performed using PubMed and Google Scholar to …

Background The rapid spread of the severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2), and coronavirus disease 2019 (COVID‐19), has caused more than 3.9 …